PMID- 34926655 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220429 IS - 2305-5839 (Print) IS - 2305-5847 (Electronic) IS - 2305-5839 (Linking) VI - 9 IP - 21 DP - 2021 Nov TI - Aqueous humor proteomic analysis of acute angle-closure glaucoma with visual field loss. PG - 1611 LID - 10.21037/atm-21-457 [doi] LID - 1611 AB - BACKGROUND: Acute angle-closure glaucoma (AACG) is an ophthalmic emergency that occurs over the course of hours or days and may cause irreversible blindness if not treated immediately. In most cases, optic nerve damage is the cause of visual field (VF) loss in AACG. There has been no reliable biomarker found to evaluate optic nerve damage to date. Aqueous humor (AH) proteome analysis might reveal the proteomic alterations in AACG and provide helpful clues in the search for an AH biomarker of optic nerve damage and VF loss. METHODS: In this study, we used the AH proteome to explore the functions of differentially expressed proteins (DEPs) during disease progression. The AH proteins from the early-stage group and late-stage group were extracted and analyzed by the data-independent acquisition (DIA) method. The DEPs functions were annotated, and parallel reaction monitoring (PRM) was used to validate the key DEPs. RESULTS: A total of 87 DEPs were found. Gene Ontology analysis showed that most DEPs were enriched in immunology, hemodynamics, and apoptosis. Ingenuity pathway analysis found that vascular endothelial growth factor (VEGF) signaling, the production of reactive oxygen species (ROS) in macrophages, and the nuclear factor erythroid 2-related factor 2 (NRF2)-mediated oxidative stress response were active pathways in the late stage of AACG. The mechanism of retinal ganglion cell (RGC) death was hypothesized on the basis of DEP functional analysis. A total of 20 DEPs were validated by using PRM, and prostaglandin-H2 D-isomerase was found to have the potential to evaluate optic nerve damage. CONCLUSIONS: This study showed that AH proteomic analysis could reveal the proteomic alterations in the pathogenesis of VF loss in AACG and help to provide objective protein biomarkers to evaluate VF loss. These findings will benefit the application of the AH proteome to clinical research. CI - 2021 Annals of Translational Medicine. All rights reserved. FAU - Xu, Jiyu AU - Xu J AD - Core Facility of Instrument, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China. FAU - Zhao, Liangliang AU - Zhao L AD - Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, China. FAU - Liu, Xiang AU - Liu X AD - Core Facility of Instrument, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China. AD - Shanghai AB Sciex Analytical Instrument Trading Co., Ltd Beijing Branch Company, Beijing, China. FAU - Sun, Haidan AU - Sun H AD - Core Facility of Instrument, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China. FAU - Liu, Xiaoyan AU - Liu X AD - Core Facility of Instrument, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China. FAU - Guo, Zhengguang AU - Guo Z AD - Core Facility of Instrument, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China. FAU - Wang, Ying AU - Wang Y AD - Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, China. FAU - Sun, Wei AU - Sun W AD - Core Facility of Instrument, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China. LA - eng PT - Journal Article PL - China TA - Ann Transl Med JT - Annals of translational medicine JID - 101617978 PMC - PMC8640911 OTO - NOTNLM OT - Aqueous humor (AH) OT - acute angle-closure glaucoma (AACG) OT - proteome OT - visual field (VF) loss COIS- Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://dx.doi.org/10.21037/atm-21-457). XL was employed by Shanghai AB Sciex Analytical Instrument Trading Co., Ltd. The other authors have no conflicts of interest to declare. EDAT- 2021/12/21 06:00 MHDA- 2021/12/21 06:01 PMCR- 2021/11/01 CRDT- 2021/12/20 06:19 PHST- 2021/01/29 00:00 [received] PHST- 2021/09/03 00:00 [accepted] PHST- 2021/12/20 06:19 [entrez] PHST- 2021/12/21 06:00 [pubmed] PHST- 2021/12/21 06:01 [medline] PHST- 2021/11/01 00:00 [pmc-release] AID - atm-09-21-1611 [pii] AID - 10.21037/atm-21-457 [doi] PST - ppublish SO - Ann Transl Med. 2021 Nov;9(21):1611. doi: 10.21037/atm-21-457.